These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8070932)

  • 1. First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin.
    Almog R; Block C; Gdalevich M; Lev B; Wiener M; Ashkenazi S
    Infection; 1994; 22(2):69-71. PubMed ID: 8070932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal disease in Italy.
    Stroffolini T; Congiu ME; Occhionero M; Mastrantonio P
    J Infect; 1989 Jul; 19(1):69-74. PubMed ID: 2506286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal disease in the Israel Defense Force: epidemiologic trends and new challenges.
    Grotto I; Block C; Lerman Y; Wiener M; Ashkenazi S
    Isr J Med Sci; 1995 Jan; 31(1):54-8. PubMed ID: 7836050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An outbreak of serogroup B:15:P1.16 meningococcal disease, Frederiksborg County, Denmark, 1987-9.
    Samuelsson S; Ege P; Berthelsen L; Lind I
    Epidemiol Infect; 1992 Feb; 108(1):19-30. PubMed ID: 1547836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual report of the Australian Meningococcal Surveillance Programme, 1998. The Australian Meningococcal Surveillance Programme.
    Commun Dis Intell; 1999 Nov; 23(12):317-23. PubMed ID: 10615794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive meningococcal disease: patient and strain characteristics set new challenge for prevention and control.
    Paret G; Keller N; Barzilai A; Zemach M; Guttman D; Vardi A; Shatzberg G; Cohen H; Barzilay Z
    Infection; 1999; 27(4-5):261-4. PubMed ID: 10885839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994.
    Erickson L; De Wals P
    Clin Infect Dis; 1998 May; 26(5):1159-64. PubMed ID: 9597245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis.
    Yagupsky P; Ashkenazi S; Block C
    Lancet; 1993 May; 341(8853):1152-3. PubMed ID: 8097834
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular epidemiology of an outbreak of meningococcal disease in a university community.
    Edmond MB; Hollis RJ; Houston AK; Wenzel RP
    J Clin Microbiol; 1995 Aug; 33(8):2209-11. PubMed ID: 7559983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serogroup C meningococcal outbreaks in the United States. An emerging threat.
    Jackson LA; Schuchat A; Reeves MW; Wenger JD
    JAMA; 1995 Feb; 273(5):383-9. PubMed ID: 7823383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing.
    Baethgen LF; Weidlich L; Moraes C; Klein C; Nunes LS; Cafrune PI; Lemos AP; Rios SS; Abreu MF; Kmetzsch C; Sperb AF; Riley LW; Rossetti ML; Zaha A
    Trop Med Int Health; 2008 Jan; 13(1):31-40. PubMed ID: 18290999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.
    Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A
    J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemoprophylaxis of cerebrospinal meningitis using rifampin in a military population.
    Chapalain JC; Guibourdenche M; Perrier-Gros-Claude JD; Bartoli M; Riou JY
    Pathol Biol (Paris); 1992 Mar; 40(3):230-3. PubMed ID: 1608666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
    Krízová P; Musílek M; Kalmusová J
    Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal disease in Africa.
    Hart CA; Cuevas LE
    Ann Trop Med Parasitol; 1997 Oct; 91(7):777-85. PubMed ID: 9625934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the use of mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease.
    Jackson LA; Alexander ER; DeBolt CA; Swenson PD; Boase J; McDowell MG; Reeves MW; Wenger JD
    Pediatr Infect Dis J; 1996 Nov; 15(11):992-8. PubMed ID: 8933547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
    Tsang RS; Squires SG; Tam TW
    Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal disease in urban south western Sydney, 1990-1994.
    Munro R; Kociuba K; Jelfs J; Brown J; Crone S; Chant K
    Aust N Z J Med; 1996 Aug; 26(4):526-32. PubMed ID: 8873936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual report of the Australian Meningococcal Surveillance Programme, 1999.
    Commun Dis Intell; 2000 Jul; 24(7):181-9. PubMed ID: 10981347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis.
    Scholten RJ; Bijlmer HA; Valkenburg HA; Dankert J
    Epidemiol Infect; 1994 Feb; 112(1):115-24. PubMed ID: 8119350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.